Trial intelligence / Profile preview

ProMPT

ISRCTN84968882Phase 4Completed

Sponsor
University Hospitals Bristol and Weston NHS Foundation Trust
Start
Feb 2010
Modality
Small Molecules
01

Overview

Phase 4, randomised trial of propofol in cardiac disease, coronary arteriosclerosis and aortic valve disease (AVD) (2 arms), sponsored by University Hospitals Bristol and Weston NHS Foundation Trust. Primary endpoint: Myocardial injury. Started Feb 2010; status: completed.

02

Drugs

propofol
03

Conditions

cardiac diseasecoronary arteriosclerosisaortic valve disease (AVD)

Beyond the preview

Go deeper on ISRCTN84968882.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN84968882.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call